Low doses of cocaine decrease, and high doses increase, anxiety-like behavior and brain progestogen levels among intact rats

Hormones and Behavior

Volumn 57, Issue 4-5, 2010, Pages 474-480

  Kohtz, Amy S ^a   Paris, Jason J ^a   Frye, Cheryl A ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Allopregnanolone; Anxiety; Estrous cycle; Progesterone; Psychomotor stimulation; Sexual behavior

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; COCAINE; GESTAGEN; STEROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN LEVEL; BRAIN TISSUE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ESTRUS CYCLE; FEMALE; HORMONE ACTION; HORMONE DETERMINATION; MALE; MATING; NEUROENDOCRINE SYSTEM; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; RAT; SEX DIFFERENCE; SEXUAL BEHAVIOR;

ANIMALS; ANXIETY; BRAIN CHEMISTRY; COCAINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROUS CYCLE; FEMALE; MALE; MOTOR ACTIVITY; PREGNANOLONE; PROGESTERONE; PROGESTINS; RATS; SEXUAL BEHAVIOR, ANIMAL;

EID: 77950951837     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2010.02.005     Document Type: Article

References (90)

1. Ambrose-Lanci L.M., Sterling R.C., Weinstein S.P., Van Bockstaele E.J. The influence of intake urinalysis, psychopathology measures, and menstrual cycle phase on treatment compliance. Am. J. Addict. 2009, 18:167-172.
2. Andreen L., Sundstrom-Poromaa I., Bixo M., Nyberg S., Backstrom T. Allopregnanolone concentration and mood-a bimodal association in postmenopausal women treated with oral progesterone. Psychopharmacology (Berl.) 2006, 187:209-221.
3. Andreen L., Nyberg S., Turkmen S., van Wingen G., Fenandez G., Backstrom T. Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABA(A) modulators. Psychoneuroendocrinology 2009, 34:1121-1132.
4. Becker J.B., Molenda H., Hummer D.L. Gender differences in the behavioral responses to cocaine and amphetamine. Implications for mechanisms mediating gender differences in drug abuse. Ann. N.Y. Acad. Sci. 2001, 937:172-187.
5. Beyer C., Hoffman K.L., Gonzalez-Flores O. Neuroendocrine regulation of estrous behavior in the rabbit: similarities and differences with the rat. Horm. Behav. 2007, 52:2-11.
6. Bitran D., Klibansky D.A., Marin G.A. The neurosteroid pregnanolone prevents the anxiogenic-like effect of inescapable shock in the rat. Psychopharmacology (Berl.) 2000, 151:31-37.
7. Blaustein J.D. Neuroendocrine regulation of feminine sexual behavior: lessons from rodent models and thoughts about humans. Annu. Rev. Psychol. 2008, 59:93-118.
8. Calogero A.E., Gallucci W.T., Kling M.A., Chrousos G.P., Gold P.W. Cocaine stimulates rat hypothalamic corticotrophin-releasing hormone secretion in vitro. Brain Res. 1989, 505:7-11.
9. Carroll M.E., Lynch W.J., Roth M.E., Morgan A.D., Cosgrove K.P. Sex and estrogen influence drug abuse. Trends Pharmacol. Sci. 2004, 25:273-279.
10. Cocores J.A., Miller N.S., Pottash A.C., Gold M.S. Sexual dysfunction in abusers of cocaine and alcohol. Am. J. Drug Alcohol Abuse 1988, 14:169-173.
11. Crombag H.S., Mueller H., Browman K.E., Badiani A., Robinson T.E. A comparison of two behavioral measures of psychomotor activation following intravenous amphetamine or cocaine: dose- and sensitization-dependent changes. Behav. Pharmacol. 1999, 10:205-213.
12. Devall A.J., Liu Z.W., Lovick T.A. Hyperalgesia in the setting of anxiety: sex differences and effects of the oestrous cycle in Wistar rats. Psychoneuroendocrinology 2009, 34:587-596.
13. Elwan O., Madkour O., Kamal I., Abdallah M. Steroid contraceptives: neuro-psychiatric and electroencephalographic complications. J. Int. Med. Res. 1973, 1:534-547.
14. Engin E., Treit D. The anxiolytic-like effects of allopregnanolone vary as a function of intracerebral microinfusion site: the amygdala, medial prefrontal cortex, or hippocampus. Behav. Pharmacol. 2007, 18:461-470.
15. Erskine M.S. Effects of paced coital stimulation on estrus duration in intact cycling rats and ovariectomized and ovariectomized-adrenalectomized hormone-primed rats. Behav. Neurosci. 1985, 99:151-161.
16. Evans S.M., Foltin R.W. Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men. Neuropsychopharmacology 2006, 31:659-674.
17. Evans S.M., Foltin R.W. Pharmacokinetics of repeated doses of intravenous cocaine across the menstrual cycle in Rhesus monkeys. Phamacol. Biochem. Behav. 2006, 83:56-66.
18. Evans S.M., Haney M., Foltin R.W. The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle. Psychopharmacology (Berl.) 2002, 159:397-406.
19. Festa E.D., Quinones-Jenab V. Gonadal hormones provide the biological basis for sex differences in behavioral responses to cocaine. Horm. Behav. 2004, 446:509-519.
20. Finn D.A., Phillips T.J., Okorn D.M., Chester J.A., Cunningham C.L. Rewarding effect of the neuroactive steroid 3 alpha-hydroxy-5 alpha-pregnan-20-one in mice. Pharmacol. Biochem. Behav. 1997, 56:261-264.
21. Fontana D.J., Commissaris R.L. Effects of cocaine on conflict behavior in the rat. Life Sci. 1989, 45:819-827.
22. Frantz K.J., O'Dell L.E., Parsons L.H. Behavioral and neurochemical responses to cocaine in periadolescent and adult rats. Neuropsychopharmacology 2007, 32:625-637.
23. Frye C.A. Progestins influence motivation, reward, conditioning, stress, and/or response to drugs of abuse. Pharmacol. Biochem. Behav. 2007, 86:209-219.
24. Frye C.A., Bayon L.E. Mating stimuli influence endogenous variations in the neurosteroids 3alpha, 5alpha-THP and 3alpha-diol. J. Neuroendocrinol. 1999, 11:839-847.
25. Frye C.A., Bayon L.E., Pursnani N.K., Purdy R.H. The neurosteroids, progesterone and 3alpha, 5alpha-THP, enhance sexual motivation, receptivity, and proceptivity in female rats. Brain Res. 1998, 808:72-83.
26. Frye C.A., Erskine M.S. Influence of time of mating and paced copulation on induction of pseudopregnancy in cyclic female rats. J. Reprod. Fertil. 1990, 90:375-385.
27. Frye C.A., McCormick C.M., Coopersmith C., Erskine M.S. Effects of paced and non-paced mating stimulation on plasma progesterone, 3 alpha-diol and cort. Psychoneuroendocrinology 1996, 21:431-439.
28. Frye C.A., Paris J.J., Rhodes M.E. Engaging in paced mating, but neither exploratory, anti anxiety, nor social behavior, increases 5alpha-reduced progestin concentrations in midbrain, hippocampus, striatum, and cortex. Reproduction 2007, 133:663-674.
29. Frye C.A., Paris J.J., Rhodes M.E. Exploratory, anti-anxiety, social, and sexual behaviors of rats in behavioral estrus is attenuated with inhibition of 3alpha, 5alpha-THP formation in the midbrain ventral tegmental area. Behav. Brain Res. 2008, 193:269-276.
30. Frye C.A., Paris J.J., Rhodes M.E. Increasing 3alpha, 5alpha-THP following inhibition of neurosteroid biosynthesis in the ventral tegmental area reinstates anti-anxiety, social and sexual behavior of naturally receptive rats. Reproduction 2009, 137:119-128.
31. Frye C.A., Petralia S.M., Rhodes M.E. Estrus cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3α,5α-THP. Pharmacol. Biochem. Behav. 2000, 67:1-10.
32. Frye C.A., Rhodes M.E. Progestin concentrations are increased following paced mating in midbrain, hippocampus, diencephalon, and cortex of rats in behavioral estrus, but only in midbrain of diestrous rats. Neuroendocrinology 2006, 83:336-347.
33. Frye C.A., Rhodes M.E. Infusions of 5-alpha-pregnan-3-alpha-ol-20-one (3alpha, 5alpha-THP) to the ventral tegmental area, but not the substantia nigra, enhance exploratory, anti-anxiety, social and sexual behaviours and concomitantly increase 3alpha, 5alpha-THP concentrations in the hippocampus, diencephalon and cortex of ovariectomised oestrogen-primed rats. J. Neuroendocrinol. 2006, 18:960-975.
34. Frye C.A., Walf A.A. Estrogen and/or progesterone administered systemically or to the amygdala can have anxiety-, fear-, and pain-reducing effects in ovariectomized rats. Behav. Neurosci. 2004, 118:306-313.
35. Frye C.A., Walf A.A., Petralia S.M. In the ventral tegmental area, progestins have actions at D1 receptors for lordosis of hamsters and rats that involve GABAA receptors. Horm. Behav. 2006, 50:332-337.
36. Frye C.A., Walf A.A., Sumida K. Progestins' actions in the VTA to facilitate lordosis involve dopamine-like type 1 and 2 receptors. Phamacol. Biochem. Behav. 2004, 78:405-418.
37. Fuchs R.A., Evans K.A., Mehta R.H., Case J.M., See R.E. Influence of sex and estrous cyclicity on conditioned cue-induced reinstatement of cocaine-seeking behavior in rats. Psychopharmacology (Berl.) 2005, 179:662-672.
38. Gallo M.A., Smith S.S. Progesterone withdrawal decreases latency to and increases duration of electrified prod burial: a possible rat model of PMS anxiety. Pharmacol. Biochem. Behav. 1993, 46:897-904.
39. Goeders N.E. Stress and cocaine addiction. J. Pharmacol. Exp. Ther. 2002, 301:785-789.
40. Hardy D.F., DeBold J.F. Effects of coital stimulation upon behavior of the female rat. J. Comp. Physiol. Psychol. 1972, 78:400-408.
41. Holder M.K., Hadjimarkou M.M., Zup S.L., Blutstein T., Benham R.S., McCarthy M.M., Mong J.A. Methamphetamine facilitates female sexual behavior and enhances neuronal activation in the medial amygdala and ventromedial nucleus of the hypothalamus. Psychoneuroendocrinology 2009, (Electronic publication).
42. Horvath K.J., Calsyn D.A., Terry C., Cotton A. Erectile dysfunction medication use among men seeking substance abuse treatment. J. Addict. Dis. 2007, 26:7-13.
43. Hu M., Becker J.B. Effects of sex and estrogen on behavioral sensitization to cocaine in rats. J. Neurosci. 2003, 23:693-699.
44. Jain N.S., Hirani K., Chopde C.T. Reversal of caffeine-induced anxiety by neurosteroid 3-alpha-hydroxy-5-alpha-pregnane-20-one in rats. Neuropharmacology 2005, 48:627-638.
45. de Jong I.E., Steenbergen P.J., de Kloet E.R. Behavioral sensitization to cocaine: cooperation between glucocorticoids and epinephrine. Psychopharmacology (Berl.) 2009, 204:693-703.
46. Kaufman M.J., Levin J.M., Maas L.C., Kukes T.J., Villafuerte R.A., Dostal K., Lukas S.E., Mendelson J.H., Cohen B.M., Renshaw P.F. Cocaine-induced cerebral vasoconstriction differs as a function of sex and menstrual cycle phase. Biol. Psychiatry 2001, 49:774-781.
47. Kendirci M., Pradhan L., Trost L., Gur S., Chandra S., Agrawal K.C., Hellstrom W.J. Peripheral mechanisms of erectile dysfunction in a rat model of chronic cocaine use. Eur. Urol. 2007, 52:555-563.
48. Koob G. Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 2009, 56:18-31.
49. Kosten T.A., Gawin F.H., Kosten T.R., Rounsaville B.J. Gender differences in cocaine use and treatment response. Subst. Abuse Treat. 1993, 10:63-66.
50. Kosten T.A., Zhang X.Y. Sex differences in non-reinforced responding for cocaine. Am. J. Drug Alcohol Abuse 2008, 34:472-488.
51. Le Moal M. Drug Abuse: vulnerability and transition to addiction. Pharmacopsychiatry 2009, 42:S42-S55.
52. Lopez H.H., Webb S.A., Nash S. Cannabinoid receptor antagonism increases female sexual motivation. Pharmacol. Biochem. Behav. 2009, 92:17-24.
53. Lopez-Ojeda W., Welsh M.L., Segarra A.C. Estrous cyclicity and the locomotor response to acute and repeated cocaine administration. FASEB J. 2008, 22:946.6.
54. Lukas S.E., Sholar M., Lundahl L.H., Lamas X., Kouri E., Wines J.D., Kragie L., Mendelson J.H. Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers. Psychopharmacology (Berl.) 1996, 125:346-354.
55. Lynch W.J. Acquisition and maintenance of cocaine self-administration in adolescent rats: effects of sex and gonadal hormones. Psychopharmacology (Berl.) 2008, 197:237-246.
56. Lynch W.J., Carroll M.E. Reinstatement of cocaine self-administration in rats: sex differences. Psychopharmacology (Berl.) 2000, 148:196-200.
57. Lynch W.J., Kalayasiri R., Sughodhabirom A., Pittman B., Vladimir C., Morgan P.T., Malison R.T. Subjective responses and cardiovascular effects of self-administered cocaine in cocaine-abusing men and women. Addict. Biol. 2008, 13:403-410.
58. Lynch W.J., Roth M.E., Carroll M.E. Biological basis of sex differences in drug abuse: preclinical and clinical studies. Psychopharmacology (Berl.) 2002, 164:121-137.
59. Mendelson J.H. Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers. Psychopharmacology (Berl.) 1996, 125:346-354.
60. Mendelson J.H., Mello N.K., Sholar M.B., Siegel A.J., Kaufman M.J., Levin J.M., Renshaw P.F., Cohen B.M. Cocaine pharmacokinetics in men and in women during the follicular and luteal phases of the menstrual cycle. Neuropsychopharmacology 2008, 21:294-303.
61. Muller C.P., Carey R.J., Wilkisz M., Schwenzner S., Jocham G., Huston J.P., De Souza Silva M.A. Acute anxiolytic effects of cocaine: the role of test latency and activity phase. Pharmacol. Biochem. Behav. 2008, 89:218-226.
62. Niyomchai T., Akhavan A., Festa E.D., Lin S.N., Lamm L., Foltz R., Quinones-Jenab V. Estrogen and progesterone affect cocaine pharmacokinetics in female rats. Brain Res. Bull. 2006, 68:310-314.
63. Pallonen U.E., Williams M.L., Timpson S.C., Bowen A., Ross M.W. Personal and partner measures in stages of consistent condom use among African-American heterosexual crack cocaine smokers. AIDS Care 2008, 20:205-213.
64. Patchev V.K., Hassan A.H., Holsboer D.F., Almeida O.F. The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharamcology 1996, 15:533-540.
65. Patchev V.K., Shoaib M., Holsboer F., Almeida O.F. The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience 1994, 62:265-271.
66. Perrotti L.I., Russo S.J., Fletcher H., Chin J., Webb T., Jenab S. Ovarian hormones modulate cocaine-induced locomotor and stereotypic activity. Ann. N.Y. Acad. Sci. 2001, 937:202-216.
67. Petralia S.M., Jahagirdar V., Frye C.A. Inhibiting biosynthesis and/or metabolism of progestins in the ventral tegmental area attenuates lordosis of rats in behavioural oestrus. J. Neuroendocrinol. 2005, 17:545-552.
68. Pfaus J.G., Smith W.J., Coopersmith C.B. Appetitive and consummatory sexual behaviors of female rats in bilevel chambers. I. A correlational and factor analysis and the effects of ovarian hormones. Horm. Behav. 1999, 35:224-240.
69. Picazo O., Fernandez-Guasti A. Anti-anxiety effects of progesterone and some of its reduced metabolites: an evaluation using the burying behavior test. Brain Res. 1995, 680:135-141.
70. Quiñones-Jenab V., Ho A., Schlussman S.D., Franck J., Kreek M.J. Estrous cycle differences in cocaine-induced stereotypic and locomotor behaviors in Fischer rats. Behav. Brain Res. 1999, 101:15-20.
71. Quiñones-Jenab V., Minerly A.C., Niyomchia T., Akahvan A., Jenab S., Frye C. Progesterone and allopregnanolone are induced by cocaine in serum and brain tissues of male and female rats. Pharmacol. Biochem. Behav. 2008, 89:292-297.
72. Reddy D.S., Kulkarni S.K. Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice. Brain Res. 1997, 752:61-71.
73. Reddy D.S., O'Malley B.W., Rogawski M.A. Anxiolytic activity of progesterone in progesterone receptor knockout mice. Neuropharmacology 2005, 48:14-24.
74. Roberts D.C., Bennett S.A., Vickers G.J. The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats. Psychopharmacology (Berl.) 1989, 98:408-411.
75. Rodbard, D., Hutt, D.M., 1974. Statistical analysis of radioimmunoassay and immunoradiometric assays: a generalized, weighted iterative, least squares method for logistic curve fitting. In: International Atomic Energy Agency (ed). Symposium on Radioimmunoassay and Related Procedures in Medicine, Uniput: New York, 209-233.
76. Russo S.J., Festa E.D., Fabian S.J., Gazi F.M., Kraish M., Jenab S., Quiñones-Jenab V. Gonadal hormones differentially modulate cocaine-induced conditioned place preference in male and female rats. Neuroscience 2003, 120:523-533.
77. Russo S.J., Sun W.L., Minerly A.C.E., Weierstall K., Nazarian A., Festa E.D., Niyomchai T., Akhavan A., Luine V., Jenab S., Quinones-Jenab V. Progesterone attenuates cocaine-induced conditioned place preference in female rats. Brain Res. 2008, 1189:229-235.
78. Schweizer E., Case W.G., Garcia-Espana F., Greenblatt D.J., Rickels K. Progesterone co-administration in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal severity and taper outcome. Psychopharmacology (Berl.) 1995, 117:424-429.
79. Sell L.A., Morris J.S., Bearn J., Frackowiak R.S., Friston K.J., Dolan R.J. Neural responses associated with cue evoked emotional states and heroin in opiate addicts. Drug Alcohol Depend. 2000, 60:207-216.
80. Sinha R., Fox H., Hong K.I., Sofuoglu M., Morgan P.T., Bergguist K.T. Sex steroid hormones, stress response, and drug craving in cocaine-dependent women: implications for relapse and susceptibility. Exp. Clin. Psychopharmacol. 2007, 15:445-452.
81. Sinnott R.S., Mark G.P., Finn D.A. Reinforcing effects of the neurosteroid allopregnanolone in rats. Pharmacol. Biochem. Behav. 2002, 72:923-929.
82. Sofuoglu M., Babb D.A., Hatsukami D.K. Effects of progesterone treatment on smoked cocaine response in women. Pharmacol. Biochem. Behav. 2002, 72:431-435.
83. Sofuoglu M., Dudish-Poulsen S., Nelson D., Pentel P.R., Hatsukami D.K. Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. Exp. Clin. Psychopharmacol. 1999, 7:274-283.
84. Todtenkopf M.S., Carlezon W.A. Contribution of drug doses and conditioning periods to psychomotor stimulant sensitization. Psychopharmacology (Berl.) 2006, 185:451-458.
85. Toufexis D.J., Davis C., Hammond A., Davis M. Progesterone attenuates corticotropin-releasing factor-enhanced but not fear-potentiated startle via the activity of its neuroactive metabolite, allopregnanolone. J. Neurosci. 2004, 24:10280-10287.
86. Turner J.M., de Wit H. Menstrual cycle phase and response to drugs of abuse in humans. Drug Alcohol Depend. 2006, 84:1-13.
87. Walker Q.D., Francis R., Cabassa J., Kuhn C.M. Effect of ovarian hormones and estrous cycle on stimulation of the hypothalamo-pituitary-adrenal axis by cocaine. J. Pharmacol. Exp. Ther. 2001, 297:291-298.
88. Walker Q.D., Cabassa J., Kaplan K.A., Li S.T., Haroon J., Spohr H.A., Francis R., Kuhn C.M. Sex differences in cocaine-stimulated motor behavior: disparate effects of gonadectomy. Neuropsychopharmacology 2001, 25:118-130.
89. van Wingen G.A., van Broekhoven F., Verkes R.J., Petersson K.M., Backstrom T., Buitelaar J.K., Fernandez G. Progesterone selectively increases amygdala reactivity in women. Mol. Psychiatry 2008, 13:325-333.
90. Yap J.J., Miczek K.A. Social defeat stress, sensitization, and intravenous cocaine self-administration in mice. Psychopharmacology (Berl.) 2007, 192:261-723.